| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 382.431 | 419.175 | 424.909 | 473.247 | 528.702 | 566.695 | 475.655 | 568.950 | 506.645 | 584.175 |
| Total Income - EUR | 382.543 | 419.330 | 425.030 | 473.344 | 528.774 | 566.695 | 478.158 | 608.615 | 513.003 | 604.424 |
| Total Expenses - EUR | 357.520 | 393.232 | 390.043 | 429.556 | 462.963 | 504.948 | 450.139 | 558.461 | 477.865 | 545.263 |
| Gross Profit/Loss - EUR | 25.022 | 26.098 | 34.987 | 43.788 | 65.811 | 61.747 | 28.019 | 50.155 | 35.138 | 59.161 |
| Net Profit/Loss - EUR | 20.285 | 21.165 | 30.143 | 39.039 | 60.516 | 56.718 | 23.834 | 44.188 | 30.671 | 49.812 |
| Employees | 7 | 7 | 8 | 6 | 6 | 6 | 5 | 4 | 4 | 4 |
Check the financial reports for the company - Biomax Prod Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 38.193 | 36.792 | 37.316 | 33.796 | 32.431 | 50.828 | 64.737 | 51.723 | 59.399 | 48.693 |
| Current Assets | 11.457 | 15.479 | 13.987 | 17.087 | 60.127 | 63.450 | 50.589 | 40.283 | 36.089 | 53.086 |
| Inventories | 9.120 | 11.489 | 12.102 | 13.022 | 15.075 | 16.911 | 14.646 | 18.608 | 20.095 | 26.826 |
| Receivables | 766 | 1.055 | 375 | 940 | 2.249 | 2.779 | 2.338 | 3.441 | 2.300 | 2.441 |
| Cash | 1.571 | 2.935 | 1.510 | 3.124 | 42.804 | 43.760 | 33.605 | 18.234 | 13.694 | 23.819 |
| Shareholders Funds | 20.339 | 21.219 | 34.873 | 46.061 | 84.433 | 101.956 | 100.123 | 44.236 | 74.773 | 92.482 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 29.694 | 31.316 | 16.740 | 5.338 | 8.515 | 12.664 | 15.678 | 49.013 | 22.256 | 10.651 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4621 - 4621" | |||||||||
| CAEN Financial Year |
4621
|
|||||||||
Comments - Biomax Prod Srl